Idexx Laboratories (IDXX) Other Accumulated Expenses (2010 - 2018)

Idexx Laboratories (IDXX) has reported Other Accumulated Expenses for 9 consecutive years, with $65.8 million the latest figure, recorded in Q1 2018.

• In Q1 2018, Other Accumulated Expenses rose 18.53% year-over-year to $65.8 million; the TTM figure through Mar 2018 stood at $65.8 million (up 18.53% YoY), while the FY2017 annual figure was $64.4 million, down 10.49% from the prior year.
• Other Accumulated Expenses came in at $65.8 million for Q1 2018 at Idexx Laboratories, up from $64.4 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $72.0 million in Q4 2016, with the low at $44.6 million in Q1 2014.
• Average Other Accumulated Expenses over 5 years is $58.9 million, with a median of $60.2 million recorded in 2015.
• Across the five-year window, Other Accumulated Expenses surged 38.03% in 2015 and fell 11.34% in 2017, its largest moves.
• Year by year, Other Accumulated Expenses stood at $55.7 million in 2014, then rose by 17.99% to $65.7 million in 2015, then advanced by 9.62% to $72.0 million in 2016, then dropped by 10.49% to $64.4 million in 2017, then increased by 2.18% to $65.8 million in 2018.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $65.8 million, $64.4 million, and $60.8 million for Q1 2018, Q4 2017, and Q3 2017 respectively.